Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 71288-017

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 71288-017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Dapto 350mg Ht Carton)

This is a product description for Daptomycin for Injection, which must be refrigerated and reconstituted with 7mL of 0.9% sodium chloride injection to obtain a concentration of 50mg per mL. Each vial contains approximately 350mg of Daptomycin for intravenous use. The product must be visually inspected for particulate matter prior to administration. The container closure is not made with natural rubber latex. This is a single-dose product and any unused or sterile contents should be discarded. Dosage information and instructions are provided in the package insert. The manufacturer is listed as Meitheal Pharmaceuticals, located in Chicago, Illinois.*

FDA Label Image

Vial Label (Dapto 350mg Ht Vial)

This text describes a pharmaceutical product called Daptomycin which is a injection used intravenously. It must be refrigerated and reconstituted before use. The manufacturer is Meitheal Pharmaceuticals and the product is for single-use only. The text includes some identification codes and the address of the manufacturer's office in Chicago.*

FDA Label Image

Chemical Structure (Dapto Struct)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.